FDA scientists will study drug metabolism, toxicity and drug-drug interactions in multi-organ systems to precisely determine how good these organs-on-chips are at predicting the success of a drug in clinical trials. The ultimate goal is to develop new industry standards and best practices to incorporate organs-on-chips in the FDA’s drug approval process.
More information:
https://labiotech.eu/cn-bio-innovations-organ-chips-fda/
-
font size
decrease font size
increase font size
Tuesday, 31 October 2017 15:45
The FDA Recruits British Organs-on-Chips to Speed Up Drug Development Featured
CN Bio Innovations, a spin-out from the University of Oxford, will be working with scientists from the FDA’s Centre for Drug Evaluation and Research with the aim of integrating organ-on-a-chip technology in the drug development process to improve preclinical testing while taking animals out of the equation.
Dr. rer. nat.
Menschen für Tierrechte - Tierversuchsgegner Rheinland-Pfalz e.V.